Marcus Werner Koch

36PUBLICATIONS
52CO-AUTHORS
Molecular targetsEpidemiological modellingNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jun 18, 2026
Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set.

|Mar 20, 2026
Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.

Eva Strijbis, Jop Mostert, Miguel D'Haeseleer

|Feb 04, 2026
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.

Sezgi Kaçar, David R van Nederpelt, Julia R Jelgerhuis

|Jan 28, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.

Marcus Koch, Jop Mostert, Eva M Strijbis

|Oct 21, 2025
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease.

Marcus W Koch, Lorraine V Kalia, Justyna Sarna

|Oct 10, 2025
Extended window of relapse recovery in RRMS: an analysis of the DECIDE dataset.

Jop Mostert, Eva M Strijbis, Miguel D'Haeseleer

Pageof 6

Frequent Collaborators

13 joint publications

Eva Strijbis

8 joint publications

Gary R Cutter

7 joint publications

James D Bowen

4 joint publications

Eline Me Coerver